Malaria High-Risk Populations in Namibia

NCT04094727 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3302

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Presumptive treatment with Artemether-lumefantrine (AL)
OTHER: Enhanced vector control

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]